Cargando…
Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease
BACKGROUND: Inflammatory bowel disease (IBD), which encompasses both ulcerative colitis (UC) and Crohn’s disease (CD), is a risk factor for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). AIM: To investigate the incidence of, and risk factors for,...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587926/ https://www.ncbi.nlm.nih.gov/pubmed/35150345 http://dx.doi.org/10.1007/s10620-022-07388-w |
_version_ | 1784814011815034880 |
---|---|
author | Fujiya, Mikihiro Kawaguchi, Tsutomu Arai, Shoko Isogawa, Naoki Hiro, Shintaro Matsumoto, Fumihiro Yamaguchi, Satoshi Yoshii, Noritoshi Nakamura, Mashio Matsuoka, Katsuyoshi |
author_facet | Fujiya, Mikihiro Kawaguchi, Tsutomu Arai, Shoko Isogawa, Naoki Hiro, Shintaro Matsumoto, Fumihiro Yamaguchi, Satoshi Yoshii, Noritoshi Nakamura, Mashio Matsuoka, Katsuyoshi |
author_sort | Fujiya, Mikihiro |
collection | PubMed |
description | BACKGROUND: Inflammatory bowel disease (IBD), which encompasses both ulcerative colitis (UC) and Crohn’s disease (CD), is a risk factor for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). AIM: To investigate the incidence of, and risk factors for, VTE in patients with IBD in Japan. METHODS: This was a retrospective, non-interventional study in patients with IBD from the Japan Medical Data Center claims database. Incidence rates (IRs; unique patients with events per 100 patient‐years) were calculated for VTE, DVT, and PE among the IBD, UC, and CD cohorts. Odds ratios of potential risk factors were calculated by univariate and multivariate analyses in a nested case–control design. RESULTS: Overall, 16 273 patients with IBD were included: 13 585 with UC and 3443 with CD. VTE events occurred in 1.3%, 1.2%, and 1.9% of patients with IBD, UC, and CD, respectively. In patients with IBD, UC, and CD, IRs of VTE were 0.45, 0.40, and 0.64, respectively, IRs of DVT were 0.42, 0.38, and 0.61, respectively, and IRs of PE were 0.07, 0.07, and 0.11, respectively. In patients with IBD, treatment history (immunomodulators), cardiovascular risk (hypertension, high-density lipoprotein or diabetes mellitus, and history of coronary artery disease or heart failure), malignancy, and undergoing major surgery were identified as potential risk factors for VTE in the multivariate analysis, with similar risk factors reported for patients with UC and CD. CONCLUSIONS: This large study provides insight into the incidence and risk factors for VTE in patients with IBD from Japan. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10620-022-07388-w. |
format | Online Article Text |
id | pubmed-9587926 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-95879262022-10-24 Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease Fujiya, Mikihiro Kawaguchi, Tsutomu Arai, Shoko Isogawa, Naoki Hiro, Shintaro Matsumoto, Fumihiro Yamaguchi, Satoshi Yoshii, Noritoshi Nakamura, Mashio Matsuoka, Katsuyoshi Dig Dis Sci Original Article BACKGROUND: Inflammatory bowel disease (IBD), which encompasses both ulcerative colitis (UC) and Crohn’s disease (CD), is a risk factor for venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and pulmonary embolism (PE). AIM: To investigate the incidence of, and risk factors for, VTE in patients with IBD in Japan. METHODS: This was a retrospective, non-interventional study in patients with IBD from the Japan Medical Data Center claims database. Incidence rates (IRs; unique patients with events per 100 patient‐years) were calculated for VTE, DVT, and PE among the IBD, UC, and CD cohorts. Odds ratios of potential risk factors were calculated by univariate and multivariate analyses in a nested case–control design. RESULTS: Overall, 16 273 patients with IBD were included: 13 585 with UC and 3443 with CD. VTE events occurred in 1.3%, 1.2%, and 1.9% of patients with IBD, UC, and CD, respectively. In patients with IBD, UC, and CD, IRs of VTE were 0.45, 0.40, and 0.64, respectively, IRs of DVT were 0.42, 0.38, and 0.61, respectively, and IRs of PE were 0.07, 0.07, and 0.11, respectively. In patients with IBD, treatment history (immunomodulators), cardiovascular risk (hypertension, high-density lipoprotein or diabetes mellitus, and history of coronary artery disease or heart failure), malignancy, and undergoing major surgery were identified as potential risk factors for VTE in the multivariate analysis, with similar risk factors reported for patients with UC and CD. CONCLUSIONS: This large study provides insight into the incidence and risk factors for VTE in patients with IBD from Japan. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10620-022-07388-w. Springer US 2022-02-12 2022 /pmc/articles/PMC9587926/ /pubmed/35150345 http://dx.doi.org/10.1007/s10620-022-07388-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Original Article Fujiya, Mikihiro Kawaguchi, Tsutomu Arai, Shoko Isogawa, Naoki Hiro, Shintaro Matsumoto, Fumihiro Yamaguchi, Satoshi Yoshii, Noritoshi Nakamura, Mashio Matsuoka, Katsuyoshi Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease |
title | Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease |
title_full | Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease |
title_fullStr | Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease |
title_full_unstemmed | Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease |
title_short | Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease |
title_sort | real-world insurance claims analysis of venous thromboembolism in japanese patients with inflammatory bowel disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9587926/ https://www.ncbi.nlm.nih.gov/pubmed/35150345 http://dx.doi.org/10.1007/s10620-022-07388-w |
work_keys_str_mv | AT fujiyamikihiro realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease AT kawaguchitsutomu realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease AT araishoko realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease AT isogawanaoki realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease AT hiroshintaro realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease AT matsumotofumihiro realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease AT yamaguchisatoshi realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease AT yoshiinoritoshi realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease AT nakamuramashio realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease AT matsuokakatsuyoshi realworldinsuranceclaimsanalysisofvenousthromboembolisminjapanesepatientswithinflammatoryboweldisease |